AB-182
| Code | Size | Price |
|---|
| TAR-T26506-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
AB-182 is an aziridine derivative with antitumor activity.
CAS:
54805-58-2
Formula:
C11H22N3O4P
Molecular Weight:
291.288
Purity:
0.98
SMILES:
CCOC(=O)NOP(=O)(N1CC1(C)C)N1CC1(C)C
References
1. Bardos TJ, Dunn JA, Perlman ME. Chemical mechanism of the radiation potentiating effects of 2,2-dimethylaziridine-type antitumor agents. Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1653-6. PubMed PMID: 536272.
2. Wodinsky I, Clement J, Swiniarski J, Skura A. Combined therapy with an aziridine derivative NSC 200724 (AB182) and radiation on an experimental leukemia. Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1677-80. PubMed PMID: 536276.